Skip to content

13F-HR filed by JOHNSON & JOHNSON

JOHNSON & JOHNSON filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 24 holding rows worth $878,419,000.

Accession
0001567619-22-004279
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 24 entries on the cover page, a total value of $878,419,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $878,419,000 with VALUE read as thousands by filing date, 13F file number 028-20072. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARROWHEAD PHARMACEUTICALS IN04280A100COM3,260,869$216,196,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM3,379,064$197,709,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM2,449,183$83,762,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS1,629,173$75,936,000thousands by filing date
CUE HEALTH INC229790100COM5,548,864$74,410,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK2,898,550$68,812,000thousands by filing date
CVRX INC126638105COMMON STOCK3,495,575$42,751,000thousands by filing date
XENCOR INC98401F105COMMON STOCK748,062$30,012,000thousands by filing date
PROCEPT BIOROBOTICS CORP COM74276L105Stock1,018,478$25,472,000thousands by filing date
FUSION PHARMACEUTICALS INC36118A100COM3,670,516$15,306,000thousands by filing date
ADICET BIO INC007002108COM728,944$12,749,000thousands by filing date
VOR BIOPHARMA INC929033108COM1,074,658$12,488,000thousands by filing date
POINT BIOPHARMA GLOBAL INC730541109COM1,000,000$5,600,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM1,607,044$4,194,000thousands by filing date
BIOMX INC09090D103COM2,133,402$3,413,000thousands by filing date
SOMALOGIC INC83444K105COM281,052$3,271,000thousands by filing date
NANO X IMAGING LTDM70700105ORD SHS192,429$2,798,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM394,834$1,579,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock811,295$1,249,000thousands by filing date
TRACON PHARMACEUTICALS INC89237H209COM NEW84,003$233,000thousands by filing date
PULMONX CORP745848101COM5,639$181,000thousands by filing date
SENSEONICS HLDGS INC81727U105COM54,621$146,000thousands by filing date
GRAYBUG VISION INC COM38942Q103SHS49,547$91,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM66,951$61,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-004279this filing2022-02-14acceptance time not in the bulk data set